American Beacon Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-815
Closed -$70K 87
2017
Q3
$70K Hold
815
0.84% 63
2017
Q2
$67K Hold
815
0.86% 65
2017
Q1
$68.5K Buy
+815
New +$65.3K 0.9% 59

Other funds holding LLY

American Beacon Advisors's LLY Position: Q4 2017 in Review

American Beacon Advisors sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 815 shares — an estimated $70K sold.

American Beacon Advisors first reported a position in LLY in Q1 2017 and held it in 3 quarters. The position peaked at $70K in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • American Beacon Advisors reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
  • American Beacon Advisors sold 815 Eli Lilly shares in Q4 2017, an estimated $70K.
  • American Beacon Advisors first reported a position in Eli Lilly in Q1 2017 and held it in 3 quarters.
  • American Beacon Advisors's Eli Lilly position peaked at $70K in Q3 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on American Beacon Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.